Israeli researchers from BGU develop fertility booster compound
The technology, called “groundbreaking” by the BGN Technologies, was developed by BGU’s Faculty of Health Sciences.Devdiscourse News Desk | Updated: 04-05-2018 05:30 IST | Created: 04-05-2018 05:26 IST
Ben-Gurion University's (BGU) technology transfer company BGN Technologies developed a compound which can stimulate the fertility in both men and women.
The technology, called "groundbreaking" by the firm, was developed by Prof. Esther Priel and her research group, at BGU's Faculty of Health Sciences in consultation with the In-Vitro Fertilization (IVF) Laboratory at the Soroka University Medical Center in Beersheba.
infertility is the inability to conceive a child after a certain period of time the length of which varies by country. The term can also refer to women who are unable to carry a pregnancy to term. Infertility has many different causes, including polycystic ovary syndrome and low sperm quality.
Now research at BGU is claiming they may have found a new compound that can help boost fertility in both men and women.
At the tip of a human's DNA chromosomes, there is an area in which reside telomers, which define the lifespan of cells. As people age and experience degenerative diseases, these telomeres get shorter. A shorter lifespan of the telomers also induces infertility.
Telomerase is the enzyme that is responsible for the maintenance of the telomers. The new treatment, developed by the BGU researchers, stimulates the expression of the telomerase and re-elongates the telomeres, protecting the cells from damage.
The treatment is applied as a single dose and dissipates within 24 hours. One dose speeds up egg maturation and ovulation, increases the number of ovulated eggs, and results in a larger number of viable offspring.